EUVIMEDEUVIMED entdecken
Crossref

“A randomized placebo controlled clinical trial using Homoeopathy as an adjuvant to standard care in the management of COVID-19” [Adv. Integr. Med. 12 (2025) 100502] https://doi.org/10.1016/j.aimed.2025.100502

Susan Arentz

Advances in Integrative Medicine · 2026-09 · 13 (3) · 100696

DOI: 10.1016/j.aimed.2026.100696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Integrative Medicine, 2026-09. Verfasst von Susan Arentz.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Arentz, S. (2026). “A randomized placebo controlled clinical trial using Homoeopathy as an adjuvant to standard care in the management of COVID-19” [Adv. Integr. Med. 12 (2025) 100502] https://doi.org/10.1016/j.aimed.2025.100502. Advances in Integrative Medicine, 13(3), 100696. https://doi.org/10.1016/j.aimed.2026.100696

Vancouver

Arentz S. “A randomized placebo controlled clinical trial using Homoeopathy as an adjuvant to standard care in the management of COVID-19” [Adv. Integr. Med. 12 (2025) 100502] https://doi.org/10.1016/j.aimed.2025.100502. Advances in Integrative Medicine. 2026;13(3):100696. doi:10.1016/j.aimed.2026.100696

BibTeX
@article{Arentz2026,
  author = {Arentz, Susan},
  title = {“A randomized placebo controlled clinical trial using Homoeopathy as an adjuvant to standard care in the management of COVID-19” [Adv. Integr. Med. 12 (2025) 100502] https://doi.org/10.1016/j.aimed.2025.100502},
  journal = {Advances in Integrative Medicine},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {100696},
  doi = {10.1016/j.aimed.2026.100696}
}
Kostenlos starten →